http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3147377-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98ece89004fba0de1ee280f32fab91d5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2022-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0836ec00b55dad1511669fab3246cb61 |
| publicationDate | 2022-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-3147377-A1 |
| titleOfInvention | Sublingual delivery of anti-viral agents and cb2 receptor agonists |
| abstract | A device is provided for treating inflammation, viral infection, and infectious disease conditions. The device includes a sublingual delivery film, dissolvable powder, compressed tablet, or tincture, with an ACE2 receptor binding competitor and a CB2 receptor agonist that could include cannabichromene. A composition is also provided to treat inflammation, viral infection, or infectious disease. The composition includes an ACE2 receptor binding competitor and a CB2 receptor agonist. A method is also provided for treating inflammation, viral infection, or infectious disease, including applying a sublingual delivery film, dissolvable powder, compressed tablet, or tincture, with an ACE2 receptor binding competitor and a CB2 receptor agonist. A composition for treating a patient with inflammation, viral infection and/or infectious disease is also provided, including an ACE2 receptor binding competitor and a CB2 receptor agonist. |
| priorityDate | 2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.